Adjusted EBITDA rose $5.9 million year-over-year to $15.7 million, despite sales headwinds, reflecting operational improvements and cost reductions.
Adjusted income from operations increased by $6.7 million year-over-year to $2 million, driven by $9.6 million reduction in SG&A expenses.
Adjusted pretax loss improved by $4 million year-over-year to a loss of $5.1 million, with adjusted diluted loss per share improving by $0.09 to $0.22.
Capital expenditures were $7.1 million, down from $13.6 million year-over-year, reflecting efficiency gains and completion of major program launch investments.
First quarter net sales were $240.5 million, down 7% year-over-year and 6% sequentially, impacted by program transitions and lower EV demand in North America.
Free cash flow was $18 million, a $20.7 million improvement from negative $2.7 million in prior year, marking the third consecutive quarter of strong free cash flow.
Net debt decreased by $11.7 million sequentially to $202.3 million, with a total reduction of $41 million over the last three quarters.
DRAM revenue for fiscal 2025 was a record $28.6 billion, up 62% year over year; fiscal Q4 DRAM revenue was $9 billion, up 69% year over year and 27% sequentially.
EPS for fiscal 2025 reached $8.29, a 538% increase year over year; fiscal Q4 non-GAAP EPS was $3.03, up 157% year over year and 59% sequentially.
Fiscal 2025 revenue grew nearly 50% to a record $37.4 billion, with fiscal Q4 revenue at $11.3 billion, up 46% year over year and 22% sequentially.
Free cash flow for fiscal 2025 was $3.7 billion, representing 10% of revenue; fiscal Q4 free cash flow was $803 million.
Gross margins expanded by 17 percentage points to 41% for fiscal 2025, with fiscal Q4 gross margin at 45.7%, up 670 basis points sequentially.
NAND revenue for fiscal 2025 was a record $8.5 billion, up 18% year over year; fiscal Q4 NAND revenue was $2.3 billion, down 5% year over year but up 5% sequentially.
Operating expenses in fiscal Q4 were $1.2 billion, up $81 million sequentially, driven primarily by higher R&D.
Operating income in fiscal Q4 was $4 billion, with an operating margin of 35%, up 820 basis points sequentially and 12 percentage points year over year.